Viral Kansara

Viral Kansara

Company: Clearside Biomedical

Job title: Vice President of Preclinical Development

Seminars:

End of Post-Conference Delivery Day 2:00 pm

Read more

day: Post Conference Day

Panel Discussion: Discussing the Future of AAV-Mediated Delivery 1:30 pm

Addressing the future of delivery – suprachoroidal, subretinal and robot assisted methods Discussing the suitability of subretinal delivery How can we make delivery more effective in the future?Read more

day: Post Conference Day

Recent Updates on Microinjector based Suprachoroidal Gene Therapy: Potentials & Challenges 10:00 am

SCS microinector based suprachoroidal gene delivery enables minimally invasive office-based treatment for choroiretinal diseases Nanoparticle based non-viral gene delivery via SC injection has potential to be a repeatable office-based gene therapyRead more

day: Post Conference Day

Chairs Opening Remarks 9:50 am

Read more

day: Post Conference Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.